Precedex (dexmedetomidine hydrochloride) NDC 0409-7853

Product information

Brand name (proprietary)

Precedex

Generic name (nonproprietary)

dexmedetomidine hydrochloride

Active ingredients

Dexmedetomidine hydrochloride — 4 ug/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

Hospira, Inc.

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 021038

Marketing start

Mar 24, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic alpha2-Agonists (Mechanism)General Anesthesia (Physiologic effect)

Identifiers

Product ID 0409-7853_3c5274fd-6597-4b88-babc-92e4e16c6329SPL ID 3c5274fd-6597-4b88-babc-92e4e16c6329SPL set ID 548a88c0-afda-427e-75ac-5af0cfa2224cRxCUI 284397, 309710, 1718900, 1718902, 1718906, 1718907, 1718909, 1718910, 2396891, 2396892UNII 1018WH7F9I

Pharmacologic class

Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409785324 followed by a unit qualifier and the quantity Copy

Package 00409-7853-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 021038

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.